Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
Yamamoto TM, McMellen A, Watson ZL, Aguilera J, Ferguson R, Nurmemmedov E, Thakar T, Moldovan GL, Kim H, Cittelly DM, Joglar AM, Brennecke EP, Wilson H, Behbakht K, Sikora MJ, Bitler BG.
Yamamoto TM, et al.
Mol Carcinog. 2019 Oct;58(10):1770-1782. doi: 10.1002/mc.23064. Epub 2019 Jun 10.
Mol Carcinog. 2019.
PMID: 31219654
Free PMC article.